We urge clinical operations leaders and your technology partners to consider: What issues in our last study were discovered late? Which could have been identified by end-to-end testing? Who in our ...

In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, discusses how regulatory ...

In today's ACT Brief, we explore the data overload and alert fatigue challenges in integrating wearable data into clinical ...

In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, examines the operational challenges ...

In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, explains how continuous remote ...

In today's ACT Brief, we explore how continuous remote monitoring enables early clinical interventions, FDA guidance on validating new approach methodologies as alternatives to animal testing, and the ...

Finally, we turn to how we do. Behavioral science provides powerful models for performance: motivation, ability, and environmental nudges determine whether new knowledge translates into consistent ...

In today's ACT Brief, we explore how wearable data is informing real-world clinical decision-making, a statistical method that analyzes multiple patient outcomes simultaneously to improve trial design ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...

In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, examines the operational challenges of incorporating wearable data into clinical workflows, including ...

In today's ACT Brief, we examine the technology infrastructure gap facing investigator-initiated trials, how transparency and community engagement drive vaccine adoption, and why workflow ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...